IRIS
ZANELLATI, GIOVANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 953
EU - Europa 737
AS - Asia 528
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.219
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 939
CN - Cina 504
IE - Irlanda 246
UA - Ucraina 150
FI - Finlandia 116
DE - Germania 90
SE - Svezia 50
IT - Italia 32
GB - Regno Unito 22
CA - Canada 14
FR - Francia 11
CZ - Repubblica Ceca 8
IR - Iran 7
IN - India 5
SG - Singapore 5
GR - Grecia 4
JP - Giappone 4
BE - Belgio 2
CH - Svizzera 2
AT - Austria 1
EU - Europa 1
KR - Corea 1
MY - Malesia 1
NL - Olanda 1
PT - Portogallo 1
RU - Federazione Russa 1
TR - Turchia 1
Totale 2.219
Salva come PNG Salva come JPEG
Città #
Dublin 246
Chandler 217
Jacksonville 188
Nanjing 134
Beijing 73
New York 66
Ashburn 64
Nanchang 54
Boardman 52
Changsha 48
Helsinki 47
Hebei 38
Lawrence 35
Medford 35
Princeton 35
Shenyang 35
Wilmington 31
Jiaxing 26
Tianjin 25
Hangzhou 18
Shanghai 18
Toronto 12
Dearborn 9
Pavia 9
Ann Arbor 8
Norwalk 8
Brno 7
Milan 6
Washington 6
Woodbridge 6
Jinan 5
Kunming 5
Verona 5
Henderson 4
Leawood 4
Los Angeles 4
Ningbo 4
Tokyo 4
Zhengzhou 4
Fairfield 3
Sacramento 3
Bassano del Grappa 2
Chicago 2
Fuzhou 2
Gunzenhausen 2
Mumbai 2
Munich 2
Naples 2
Pune 2
Seattle 2
Singapore 2
Taizhou 2
Zanjan 2
Alessandria 1
Andover 1
Auburn Hills 1
Berlin 1
Bolton 1
Borås 1
Brussels 1
Chennai 1
Des Moines 1
Haikou 1
Jinzhou 1
Kyjov 1
Lanzhou 1
London 1
Monmouth Junction 1
Orange 1
Piscataway 1
Rechthalten 1
Rockville 1
Shijiazhuang 1
Tappahannock 1
Turin 1
Winnipeg 1
Wuhan 1
Zurich 1
Totale 1.650
Salva come PNG Salva come JPEG
Nome #
Induzione e mantenimento di remissione clinica mediante l’utilizzo di Budesonide in paziente affetto da malattia di Crohn ad esordio giovanile, a localizzazione ileo-colonica e fenotipo steno-fistolizzante, già sottoposto a terapia immunosoppressiva, biologica, cellulare e chirurgica. 98
Clinical response to gluten withdrawal is not an indicator of coeliac disease. 87
Immunosuppressive effect of bone marrow-derived mesenchymal stromal cells on gliadin-specific T cell lines 86
A one minute questionnaire to evaluate the compliance to a gluten-free diet. 77
Adult autoimmune enteropathy treated with autologous bone marrow-derived mesenchymal stromal cells 75
Are anti-actin antibodies useful for coeliac disease diagnosis?. 73
The incidence of coeliac disease in adult first degree relatives. 72
Treatment of fistulizing Crohn’s disease with local infusions of autologus bone marrow-derived mesenchymal stromal cells 70
Clinical response to gluten withdrawal is not an indicator of coeliac disease. 70
Coeliac disese in first degree relatives: an incidence study 70
Study of the espression of receptor for advanced glycation end products (RAGE), in inflammatory bowel disease 70
Effects of Infliximab on circulating dendritic cell populations in Crohn’s disease 69
Herpes virus-6 chromosomal integration misled the management of Crohn’s disease 69
Interferon therapy for chronic hepatitis virus c infection is not associated to an increased risk to develop coeliac disease 68
Induction of immune tolerance to gluten in coeliac disease after allogeneic haematopoietic stem cell transplantation for thalassaemia major 68
Bone Marrow-Derived Mesenchymal Stromal Cells Locally Injected Induce An Up-Regulation Of Both Circulating And Mucosal Foxp3+ Regulatory T-Cells In Patients With Perianal Crohn’s Disease 68
The incidence of coeliac disease in adult first degree relatives 67
Italian translation, cultural adaptation and initial statistical validation of the inflammatory bowel disease questionnaire 67
The impact of misdiagnosing celiac disease at a referral centre. 66
Is coeliac disease overdiagnosed? 66
Treatment of fistulizing Crohn’s disease with local infusions of autologus bone marrow-derived mesenchymal stromal cells 63
The impact of misdiagnosing celiac disease at a referral centre 61
Plasma levels of soluble receptor for advanced glycation end products inversely correlate with clinical and serological activity indexes in patients with Inflammatory Bowel Disease 57
Induction Of Immune Tolerance To Gluten After Allogeneic Haematopoietic Stem Cell Transplantation (HSCT) For Thalassaemia Major. 57
Decreased Serum Levels Of Soluble Receptor For Advanced Glycation End Product (RAGE) In Patients With Inflammatory Bowel Disease (IBD) 56
Bone marrow-derived mesenchymal stromal cells locally injected for refractory fistulizing Crohn’s disease modulate serum immunoglobulins, secretory IgA, and antibody production 56
Expression Of The Soluble Form Of The Receptor For Advanced Glycation End Product (RAGE) In Patients With Inflammatory Bowel Disease (IBD) 56
Usefulness of antibodies to deamidated gliadin peptides (DGP) in coeliac disease (CD) 54
The receptor for the advanced glycation end products is overexpressed in the intestinal mucosa of patients with crohn’s disease 52
Clinical Utility Of Antibodies To Deamidated Gliadin Peptides In Coeliac Disease 52
Minimal duodenal lesions in patiens without endomysial antibody 52
Decreased Serum Levels Of Soluble Receptor For Advanced Glycation End Products Inversely Correlate With Disease Activity Indexes In Patients With Inflammatory Bowel Disease 46
Reactivation of opportunistic viral infections in inflammatory bowel disease 38
Receptor for advanced glycation end products (RAGE) expression in inflammatory bowel disease (IBD) 36
Use Of Autologous Bone Marrow-Derived Mesenchymal Stromal Cells In The Treatment Of Adult Autoimmune Enterophaty. 35
Totale 2.227
Salva come PNG Salva come JPEG
Categoria #
all - tutte 6.987
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.987
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020449 0 229 2 30 2 32 15 33 0 71 35 0
2020/2021261 31 28 8 29 0 37 0 36 8 40 36 8
2021/2022154 4 0 12 0 0 1 0 8 8 0 44 77
2022/2023638 60 64 10 35 68 56 0 27 291 10 9 8
2023/2024274 48 32 11 10 22 108 1 13 3 8 6 12
2024/202545 9 36 0 0 0 0 0 0 0 0 0 0
Totale 2.227